VitalTraq for the Detection of CRS
NCT: NCT06415656 · COMPLETED
Brief Summary
The purpose of this study is to evaluate two vital sign monitoring devices, TempTraq and VitalTraq, in patients with hematologic malignancies undergoing therapy with Chimeric antigen receptor T-cell therapy (CAR-T) or Bispecific T-cell engagers (BiTE) products. TempTraq is an axillary patch that is worn on the skin and continuously monitors a patient's body temperature. VitalTraq is a smartphone application that utilizes remote photoplethysmography technology via a 30-second facial scan to estimate the patient's blood pressure (BP), heart rate (HR), heart rate variability (HRV), and respiratory rate. These remote vital sign monitoring devices have the potential to promote earlier detection and intervention of treatment-related toxicities, including cytokine release syndrome (CRS) and febrile neutropenia.
Frequently Asked Questions
What is VitalTraq for the Detection of CRS?
VitalTraq for the Detection of CRS is a clinical trial registered under NCT06415656. Current status: COMPLETED.
What is the status of NCT06415656?
The current status of NCT06415656 (VitalTraq for the Detection of CRS) is: COMPLETED.
When did VitalTraq for the Detection of CRS start?
VitalTraq for the Detection of CRS started on 2024-10-13.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.